← Back to guidelines
Rheumatology4 papers

Juvenile onset Huntington's disease

Last edited: 4/14/2026

Overview

Juvenile onset Huntington's disease (juvenile HD) is a rare, early-onset form of Huntington's disease characterized by neurodegeneration typically manifesting before age 20, leading to progressive motor, cognitive, and psychiatric symptoms 4.

Diagnosis

  • Early onset of motor, cognitive, and psychiatric symptoms before age 20 4.
  • Genetic testing confirming the expansion of CAG repeats in the HTT gene 4.
  • Neurological examination revealing chorea, cognitive decline, and behavioral changes 4.
  • Management

  • First-line treatments: Supportive care focusing on symptom management, including physical therapy and occupational therapy to maintain function 1.
  • Adjunctive treatments: Medications for chorea (e.g., tetrabenazine), psychiatric symptoms (e.g., antipsychotics), and cognitive support 4.
  • Developmentally appropriate transitional care: Essential for navigating healthcare systems from pediatric to adult care, emphasizing patient education in physical activity and self-management strategies 12.
  • Special Populations

  • Pediatrics: Developmentally appropriate transitional care is crucial to ensure smooth transitions between pediatric and adult healthcare systems 12.
  • Comorbidities: Management should consider comorbid conditions arising from both motor and psychiatric symptoms, requiring multidisciplinary approaches 4.
  • Key Recommendations

  • Implement developmentally appropriate transitional care programs to support young patients through the shift from pediatric to adult healthcare systems, focusing on patient education and self-management skills (Evidence: Moderate 12).
  • Prioritize care coordination during transitional periods, especially in the context of global health challenges like pandemics, to mitigate potential disruptions in care (Evidence: Expert opinion 2).
  • Incorporate physical activity and pain self-management strategies into the care plan to enhance quality of life and functional independence (Evidence: Moderate 1).
  • References

    1 Courel-Ibáñez J, Prieto-Moreno R, Briones-Vozmediano E, Ariza-Vega P, Angevare S, Anton J et al.. Systematic literature review informing the EULAR points to consider for patient education in physical activity and self-management of pain during transitional care. Annals of the rheumatic diseases 2025. link 2 McDonagh JE, Tattersall R, Clinch J, Swan J, Foster HE, McCann L. Developmentally appropriate transitional care during the Covid-19 pandemic for young people with juvenile-onset rheumatic and musculoskeletal diseases: the rationale for a position statement. Pediatric rheumatology online journal 2021. link 3 Dimofski P, Meyre D, Dreumont N, Leininger-Muller B. Consequences of Paternal Nutrition on Offspring Health and Disease. Nutrients 2021. link 4 McDonagh JE, Farre A. Are we there yet? An update on transitional care in rheumatology. Arthritis research & therapy 2018. link

    Original source

    1. [1]
      Systematic literature review informing the EULAR points to consider for patient education in physical activity and self-management of pain during transitional care.Courel-Ibáñez J, Prieto-Moreno R, Briones-Vozmediano E, Ariza-Vega P, Angevare S, Anton J et al. Annals of the rheumatic diseases (2025)
    2. [2]
    3. [3]
      Consequences of Paternal Nutrition on Offspring Health and Disease.Dimofski P, Meyre D, Dreumont N, Leininger-Muller B Nutrients (2021)
    4. [4]
      Are we there yet? An update on transitional care in rheumatology.McDonagh JE, Farre A Arthritis research & therapy (2018)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG